APA (7th ed.) Citation

Meng, J., Wu, X., Sun, Z., Xun, R., Liu, M., Hu, R., & Huang, J. (2021, October). Corrigendum: Efficacy and Safety of CAR-T Cell Products Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel for the Treatment of Hematologic Malignancies: A Systematic Review and Meta-Analysis. Frontiers in Oncology.

Chicago Style (17th ed.) Citation

Meng, Jun, XiaoQin Wu, Zhen Sun, RenDe Xun, MengSi Liu, Rui Hu, and JianChao Huang. "Corrigendum: Efficacy and Safety of CAR-T Cell Products Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel for the Treatment of Hematologic Malignancies: A Systematic Review and Meta-Analysis." Frontiers in Oncology Oct. 2021.

MLA (9th ed.) Citation

Meng, Jun, et al. "Corrigendum: Efficacy and Safety of CAR-T Cell Products Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel for the Treatment of Hematologic Malignancies: A Systematic Review and Meta-Analysis." Frontiers in Oncology, Oct. 2021.